Napabucasin, Bendatax 6 mg/ ml, Bendacitabin 38 mg/ml Pulver zur Herstellung einer Infusionslösung
STEMNESS-PANC
Phase 3 small_molecule active
Quick answer
Napabucasin, Bendatax 6 mg/ ml, Bendacitabin 38 mg/ml Pulver zur Herstellung einer Infusionslösung for Histologically or cytologically confirmed advanced pancreatic adenocarcinoma that is metastatic. is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Histologically or cytologically confirmed advanced pancreatic adenocarcinoma that is metastatic.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active